Literature DB >> 32541637

Alterations in Enteroendocrine Hormones After Total Pancreatectomy With Islet Autotransplantation.

Kendall R McEachron1, Yi Yang2, James S Hodges2, Gregory J Beilman1, Timothy L Pruett1, Varvara A Kirchner1, Ty B Dunn, Martin L Freeman3, Guru Trikudanathan3, Kristine E Mulier1, Peggy Ptacek4, Melena D Bellin.   

Abstract

OBJECTIVE: When total pancreatectomy with islet autotransplantation (TPIAT) is performed for chronic pancreatitis, the pancreas and most of the duodenum are removed, with Roux-en-Y reconstruction of the gastrointestinal tract. Enteroendocrine cells in the intestines and pancreas secrete hormones coordinating digestion and motility, but anatomic reconstruction alters transit of nutrients to these cells. We hypothesized that TPIAT leads to changes in enteroendocrine hormones.
METHODS: Glucagon-like peptide 1 (GLP-1), peptide YY (PYY), and pancreatic polypeptide (PP) were measured from mixed-meal tolerance tests of 34 clinical trial participants before and 18 months after TPIAT. Area under the curve of GLP-1 and PYY-stimulated responses were calculated by trapezoidal method, and the PP response was measured as the stimulated max minus baseline (ΔPP).
RESULTS: Area under the curve of GLP-1 and PYY increased significantly after TPIAT (GLP-1 average +553.1 pg/mL per minute, P = 0.004; PYY average +4647.9 pg/mL per minute, P = 0.02). ΔPP trended toward lower after TPIAT (average, -52.2 pg/mL, P = 0.06).
CONCLUSIONS: In this novel study of enteroendocrine hormones in TPIAT patients, stimulated levels of GLP-1 and PYY were significantly higher after versus before TPIAT. ΔPP was lower after TPIAT, but not significantly. These hormone changes have potential clinical implications that warrant further research.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32541637      PMCID: PMC7321866          DOI: 10.1097/MPA.0000000000001582

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.243


  47 in total

1.  Sitagliptin treatment increases GLP-1 without improving diabetes outcomes after total pancreatectomy with islet autotransplantation.

Authors:  Kendall R McEachron; Gregory J Beilman; Melena D Bellin
Journal:  Am J Transplant       Date:  2018-10-08       Impact factor: 8.086

Review 2.  Chronic pancreatitis.

Authors:  Matthew J DiMagno; Eugene P DiMagno
Journal:  Curr Opin Gastroenterol       Date:  2013-09       Impact factor: 3.287

3.  Pancreatic polypeptide administration enhances insulin sensitivity and reduces the insulin requirement of patients on insulin pump therapy.

Authors:  Atoosa Rabiee; Panagis Galiatsatos; Rocio Salas-Carrillo; Michael J Thompson; Dana K Andersen; Dariush Elahi
Journal:  J Diabetes Sci Technol       Date:  2011-11-01

4.  Sitagliptin Treatment After Total Pancreatectomy With Islet Autotransplantation: A Randomized, Placebo-Controlled Study.

Authors:  M D Bellin; G J Beilman; T B Dunn; T L Pruett; D E R Sutherland; S Chinnakotla; J S Hodges; A Lane; P Ptacek; K L Berry; B J Hering; A Moran
Journal:  Am J Transplant       Date:  2016-08-26       Impact factor: 8.086

5.  Factors Predicting Outcomes After a Total Pancreatectomy and Islet Autotransplantation Lessons Learned From Over 500 Cases.

Authors:  Srinath Chinnakotla; Gregory J Beilman; Ty B Dunn; Melena D Bellin; Martin L Freeman; David M Radosevich; Mustafa Arain; Stuart K Amateau; J Shawn Mallery; Sarah J Schwarzenberg; Alfred Clavel; Joshua Wilhelm; R Paul Robertson; Louise Berry; Marie Cook; Bernhard J Hering; David E R Sutherland; Timothy L Pruett
Journal:  Ann Surg       Date:  2015-10       Impact factor: 12.969

6.  Alterations in hepatocyte insulin binding in chronic pancreatitis: effects of pancreatic polypeptide.

Authors:  N E Seymour; A R Volpert; E L Lee; D K Andersen; C Hernandez
Journal:  Am J Surg       Date:  1995-01       Impact factor: 2.565

Review 7.  Gastrointestinal satiety signals III. Glucagon-like peptide 1, oxyntomodulin, peptide YY, and pancreatic polypeptide.

Authors:  Sarah Stanley; Katie Wynne; Steve Bloom
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2004-05       Impact factor: 4.052

8.  Gut-hormone profile in totally pancreatectomised patients.

Authors:  H G Dammann; H S Besterman; S R Bloom; H W Schreiber
Journal:  Gut       Date:  1981-02       Impact factor: 23.059

9.  Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters.

Authors:  Carel W le Roux; Simon J B Aylwin; Rachel L Batterham; Cynthia M Borg; Frances Coyle; Vyas Prasad; Sandra Shurey; Mohammad A Ghatei; Ameet G Patel; Stephen R Bloom
Journal:  Ann Surg       Date:  2006-01       Impact factor: 12.969

10.  Interleukin-6 predicts inflammation-induced increase of Glucagon-like peptide-1 in humans in response to cardiac surgery with association to parameters of glucose metabolism.

Authors:  Corinna Lebherz; Florian Kahles; Katja Piotrowski; Michael Vogeser; Ann Christina Foldenauer; Kirsten Nassau; Erich Kilger; Nikolaus Marx; Klaus G Parhofer; Michael Lehrke
Journal:  Cardiovasc Diabetol       Date:  2016-02-03       Impact factor: 9.951

View more
  2 in total

1.  Intraportal Islet Autotransplantation Independently Improves Quality of Life After Total Pancreatectomy in Patients With Chronic Refractory Pancreatitis.

Authors:  Srinath Chinnakotla; Gregory J Beilman; David Vock; Martin L Freeman; Varvara Kirchner; Ty B Dunn; Timothy L Pruett; Stuart K Amateau; Guru Trikudanathan; Sarah J Schwarzenberg; Elissa Downs; Matthew Armfield; Karthik Ramanathan; David E R Sutherland; Melena D Bellin
Journal:  Ann Surg       Date:  2022-06-28       Impact factor: 13.787

Review 2.  Perioperative Nutritional Aspects in Total Pancreatectomy: A Comprehensive Review of the Literature.

Authors:  Niccolò Furbetta; Annalisa Comandatore; Desirée Gianardi; Matteo Palmeri; Gregorio Di Franco; Simone Guadagni; Giovanni Caprili; Matteo Bianchini; Lorenzo Maria Fatucchi; Martina Picchi; Luca Bastiani; Giandomenico Biancofiore; Giulio Di Candio; Luca Morelli
Journal:  Nutrients       Date:  2021-05-22       Impact factor: 5.717

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.